Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LIXT |
---|---|---|
09:32 ET | 1104612 | 3.93 |
09:34 ET | 1741198 | 3.72 |
09:36 ET | 954695 | 3.9199 |
09:38 ET | 2925501 | 3.92 |
09:39 ET | 1024454 | 3.78 |
09:41 ET | 613386 | 3.7499 |
09:43 ET | 399028 | 3.82 |
09:45 ET | 586809 | 3.53 |
09:48 ET | 569662 | 3.47 |
09:50 ET | 403178 | 3.48 |
09:52 ET | 237937 | 3.46 |
09:54 ET | 268618 | 3.53 |
09:56 ET | 314324 | 3.6 |
09:57 ET | 199732 | 3.525 |
09:59 ET | 341868 | 3.425 |
10:01 ET | 211147 | 3.34 |
10:03 ET | 301328 | 3.32 |
10:06 ET | 167452 | 3.38 |
10:08 ET | 187821 | 3.3665 |
10:10 ET | 88382 | 3.385 |
10:12 ET | 81980 | 3.39 |
10:14 ET | 103571 | 3.33 |
10:15 ET | 176595 | 3.4712 |
10:17 ET | 246270 | 3.5214 |
10:19 ET | 181627 | 3.51 |
10:21 ET | 144826 | 3.45 |
10:24 ET | 89228 | 3.39 |
10:26 ET | 75409 | 3.44 |
10:28 ET | 74708 | 3.4103 |
10:30 ET | 74747 | 3.4101 |
10:32 ET | 182719 | 3.5069 |
10:33 ET | 269966 | 3.5701 |
10:35 ET | 168181 | 3.54 |
10:37 ET | 139917 | 3.47 |
10:39 ET | 60020 | 3.47 |
10:42 ET | 104258 | 3.5099 |
10:44 ET | 44972 | 3.5299 |
10:46 ET | 347706 | 3.66 |
10:48 ET | 277091 | 3.62 |
10:50 ET | 181336 | 3.63 |
10:51 ET | 270701 | 3.51 |
10:53 ET | 294096 | 3.34 |
10:55 ET | 126198 | 3.3547 |
10:57 ET | 59950 | 3.36 |
11:00 ET | 249573 | 3.25 |
11:02 ET | 157167 | 3.1707 |
11:04 ET | 125724 | 3.22 |
11:06 ET | 60773 | 3.21 |
11:08 ET | 65083 | 3.2099 |
11:09 ET | 95207 | 3.2489 |
11:11 ET | 46437 | 3.2222 |
11:13 ET | 45728 | 3.2394 |
11:15 ET | 48752 | 3.2 |
11:18 ET | 48209 | 3.19 |
11:20 ET | 34789 | 3.22 |
11:22 ET | 38940 | 3.23 |
11:24 ET | 37552 | 3.2 |
11:26 ET | 135116 | 3.17 |
11:27 ET | 25108 | 3.18 |
11:29 ET | 32821 | 3.15 |
11:31 ET | 27150 | 3.165 |
11:33 ET | 15167 | 3.1397 |
11:36 ET | 25590 | 3.16 |
11:38 ET | 59119 | 3.19 |
11:40 ET | 60208 | 3.1766 |
11:42 ET | 111539 | 3.23 |
11:44 ET | 24180 | 3.23 |
11:45 ET | 23807 | 3.215 |
11:47 ET | 41466 | 3.2 |
11:49 ET | 17897 | 3.23 |
11:51 ET | 32011 | 3.22 |
11:54 ET | 30274 | 3.16 |
11:56 ET | 25139 | 3.185 |
11:58 ET | 12779 | 3.2 |
12:00 ET | 22438 | 3.19 |
12:02 ET | 19765 | 3.19 |
12:03 ET | 12846 | 3.1545 |
12:05 ET | 75723 | 3.095 |
12:07 ET | 38453 | 3.12 |
12:09 ET | 26436 | 3.115 |
12:12 ET | 21839 | 3.1005 |
12:14 ET | 8177 | 3.12 |
12:16 ET | 21074 | 3.1 |
12:18 ET | 21846 | 3.08 |
12:20 ET | 53704 | 3.0893 |
12:21 ET | 29931 | 3.1 |
12:23 ET | 50094 | 3.17 |
12:25 ET | 93670 | 3.25 |
12:27 ET | 27253 | 3.23 |
12:30 ET | 40129 | 3.22 |
12:32 ET | 7385 | 3.23 |
12:34 ET | 5849 | 3.23 |
12:36 ET | 23015 | 3.2102 |
12:38 ET | 31687 | 3.21 |
12:39 ET | 14579 | 3.23 |
12:41 ET | 11965 | 3.2391 |
12:43 ET | 75068 | 3.1951 |
12:45 ET | 44381 | 3.17 |
12:48 ET | 9600 | 3.17 |
12:50 ET | 8590 | 3.15 |
12:52 ET | 8708 | 3.1987 |
12:54 ET | 24359 | 3.24 |
12:56 ET | 67454 | 3.2803 |
12:57 ET | 48012 | 3.25 |
12:59 ET | 19525 | 3.26 |
01:01 ET | 3528 | 3.27 |
01:03 ET | 13976 | 3.2395 |
01:06 ET | 14046 | 3.2595 |
01:08 ET | 7484 | 3.25 |
01:10 ET | 5986 | 3.24 |
01:12 ET | 4552 | 3.1907 |
01:14 ET | 5237 | 3.235 |
01:15 ET | 4868 | 3.2605 |
01:17 ET | 69898 | 3.3289 |
01:19 ET | 58413 | 3.32 |
01:21 ET | 9316 | 3.33 |
01:24 ET | 36820 | 3.34 |
01:26 ET | 128525 | 3.44 |
01:28 ET | 66158 | 3.45 |
01:30 ET | 182955 | 3.34 |
01:32 ET | 28057 | 3.35 |
01:33 ET | 8496 | 3.355 |
01:35 ET | 17924 | 3.3481 |
01:37 ET | 28400 | 3.39 |
01:39 ET | 43125 | 3.43 |
01:42 ET | 32156 | 3.41 |
01:44 ET | 11724 | 3.435 |
01:46 ET | 16314 | 3.4101 |
01:48 ET | 79109 | 3.3223 |
01:50 ET | 56304 | 3.3501 |
01:51 ET | 15766 | 3.3501 |
01:53 ET | 111268 | 3.44 |
01:55 ET | 19121 | 3.41 |
01:57 ET | 14645 | 3.3601 |
02:00 ET | 11820 | 3.385 |
02:02 ET | 7220 | 3.4 |
02:04 ET | 16731 | 3.38 |
02:06 ET | 458 | 3.37 |
02:08 ET | 25441 | 3.37 |
02:09 ET | 34131 | 3.33 |
02:11 ET | 8053 | 3.3395 |
02:13 ET | 8550 | 3.335 |
02:15 ET | 11005 | 3.3501 |
02:18 ET | 18334 | 3.38 |
02:20 ET | 33390 | 3.3707 |
02:22 ET | 12361 | 3.38 |
02:24 ET | 9741 | 3.36 |
02:26 ET | 17907 | 3.37 |
02:27 ET | 2300 | 3.38 |
02:29 ET | 10436 | 3.37 |
02:31 ET | 162274 | 3.53 |
02:33 ET | 86715 | 3.5701 |
02:36 ET | 26688 | 3.55 |
02:38 ET | 65644 | 3.42 |
02:40 ET | 68240 | 3.43 |
02:42 ET | 30567 | 3.4283 |
02:44 ET | 30197 | 3.4537 |
02:45 ET | 51030 | 3.43 |
02:47 ET | 10806 | 3.46 |
02:49 ET | 18972 | 3.48 |
02:51 ET | 17829 | 3.4501 |
02:54 ET | 33787 | 3.45 |
02:56 ET | 56371 | 3.28 |
02:58 ET | 34515 | 3.28 |
03:00 ET | 15147 | 3.3 |
03:02 ET | 14836 | 3.2899 |
03:03 ET | 25867 | 3.24 |
03:05 ET | 8384 | 3.24 |
03:07 ET | 23150 | 3.24 |
03:09 ET | 24892 | 3.27 |
03:12 ET | 13136 | 3.3 |
03:14 ET | 5339 | 3.2977 |
03:16 ET | 15149 | 3.23 |
03:18 ET | 4486 | 3.28 |
03:20 ET | 7286 | 3.29 |
03:21 ET | 9177 | 3.29 |
03:23 ET | 5990 | 3.28 |
03:25 ET | 46465 | 3.3 |
03:27 ET | 9047 | 3.28 |
03:30 ET | 14521 | 3.3 |
03:32 ET | 12822 | 3.28 |
03:34 ET | 119519 | 3.44 |
03:36 ET | 45660 | 3.48 |
03:38 ET | 36911 | 3.4501 |
03:39 ET | 45308 | 3.52 |
03:41 ET | 33466 | 3.48 |
03:43 ET | 33113 | 3.41 |
03:45 ET | 9523 | 3.41 |
03:48 ET | 25382 | 3.375 |
03:50 ET | 10811 | 3.38 |
03:52 ET | 5725 | 3.385 |
03:54 ET | 15428 | 3.4 |
03:56 ET | 106072 | 3.48 |
03:57 ET | 36561 | 3.47 |
03:59 ET | 96155 | 3.52 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Lixte Biotechnology Holdings Inc | 7.9M | -1.3x | --- |
CeCors Inc | 7.9M | 0.0x | --- |
Gamida Cell Ltd | 7.9M | -0.1x | --- |
First Wave BioPharma Inc | 7.8M | 0.0x | --- |
Protagenic Therapeutics Inc | 8.1M | -2.0x | --- |
Theriva Biologics Inc | 8.3M | -0.4x | --- |
Lixte Biotechnology Holdings, Inc. is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The Company’s product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers. The Company encompasses that inhibitors of protein phosphatases have broad therapeutic potential not only for cancer but also for other debilitating and life-threatening diseases. It is focused on development activities of its LB-100 series of drugs. The LB-100 series have activity against a broad spectrum of common and rarer human cancers in cell culture systems. In addition, lead compounds of the LB-100 series have anti-cancer activity in animal models of glioblastoma multiforme, neuroblastoma, and medulloblastoma, all cancers of neural tissue.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.9M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 2.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.28 |
EPS | $-2.77 |
Book Value | $1.78 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.